We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Mylan is faced with a new rival to its allergic reaction shot, EpiPen (epinephrine), after the FDA approved a generic from San Diego’s Adamis Pharmaceuticals.